Concepedia

MyongHak Ri

MR

Statistics

Publications

13

Citations

703

H-Index

13

Active since

2018

Affiliations

Yanbian University(Current)

University of Chinese Academy of Sciences

National Center for Nanoscience and Technology

Qingdao University of Science and Technology

Beihua University

MyongHak Ri is an author at Yanbian University specializing in molecular oncology, oncology, and life sciences.

Publications per year

2018–2023

13

Publications

13

Fast and Selective Semihydrogenation of Alkynes by Palladium Nanoparticles Sandwiched in Metal–Organic Frameworks

Kwanghak Choe, Fengbin Zheng, Hui Wang et al. · Angewandte Chemie International Edition · 2019 · 160 citations · Full text

Natural Sciences, Chemical Engineering, Chemistry +17

Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1α and STAT3 in human colon cancer cells

Zhe Wang, Ming Yue Li, Zhi Hong Zhang et al. · Pharmacological Research · 2020 · 109 citations

Medicine, Oncology, Pharmacology +14

Licochalcone A inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-κB and Ras/Raf/MEK pathways

Xueshuang Liu, Yue Xing, Mingyue Li et al. · Journal of Ethnopharmacology · 2021 · 75 citations

Life Sciences, Cell Biology, Oncology +17

Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer

Hong Xiang Zuo, Yong Jun Jin, Zhe Wang et al. · Journal of Ethnopharmacology · 2020 · 69 citations

Medicine, Cell Biology, Oncology +14

Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation

Jing Ying Wang, Ming Wen Jiang, Ming Yue Li et al. · The Journal of Nutritional Biochemistry · 2021 · 52 citations

Medicine, Molecular Biology, Oncology +14

1–5 of 13